Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry

This Viewpoint uses 3 recent legal antitrust cases filed by pharmaceutical companies against each other to identify mechanisms by which companies suppress competition and keep drug prices inflated, and emphasizes the role of antitrust law as a potentially positive means to open markets and increase access to affordable drugs.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research